ANGO AngioDynamics, Inc. Stock Quote

publish chart | save to portfolio | create alert

ANGO [NASD]

AngioDynamics, Inc.

Healthcare | Medical Instruments & Supplies | USA

statements

Index	-	P/E	-	EPS (ttm)	-4.46	Insider Own	2.60%	Shs Outstand	38.16M	Perf Week	6.48%
Market Cap	581.17M	Forward P/E	104.01	EPS next Y	0.15	Insider Trans	4.33%	Shs Float	36.74M	Perf Month	40.79%
Income	-169.80M	PEG	-	EPS next Q	-0.02	Inst Own	96.80%	Short Float	3.36%	Perf Quarter	67.29%
Sales	268.30M	P/S	2.17	EPS this Y	-77.80%	Inst Trans	-1.09%	Short Ratio	4.31	Perf Half Y	27.63%
Book/sh	11.93	P/B	1.28	EPS next Y	764.71%	ROA	-25.80%	Target Price	16.00	Perf Year	0.53%
Cash/sh	-	P/C	-	EPS next 5Y	15.00%	ROE	-31.80%	52W Range	7.48 - 17.24	Perf YTD	-4.50%
Dividend	-	P/FCF	-	EPS past 5Y	4.38%	ROI	-33.50%	52W High	-11.31%	Beta	0.88
Dividend %	-	Quick Ratio	2.20	Sales past 5Y	-5.80%	Gross Margin	55.10%	52W Low	104.41%	ATR	0.71
Employees	800	Current Ratio	3.60	Sales Q/Q	6.40%	Oper. Margin	-63.90%	RSI (14)	77.73	Volatility	5.24% 5.08%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-231.40%	Profit Margin	-63.30%	Rel Volume	1.77	Prev Close	14.14
Shortable	Yes	LT Debt/Eq	0.09	Earnings	Sep 29 BMO	Payout	-	Avg Volume	286.63K	Price	15.29
Recom	2.30	SMA20	19.79%	SMA50	29.48%	SMA200	46.72%	Volume	506,408	Change	8.13%

Nov-25-20

Upgrade

Raymond James

Mkt Perform → Strong Buy

$18

Apr-08-20

Downgrade

KeyBanc Capital Markets

Overweight → Sector Weight

Apr-01-19

Upgrade

KeyBanc Capital Markets

Sector Weight → Overweight

Apr-03-18

Upgrade

Raymond James

Mkt Perform → Outperform

Jan-05-18

Downgrade

Craig Hallum

Buy → Hold

Apr-07-17

Reiterated

Cantor Fitzgerald

Overweight

$20 → $21

Mar-30-17

Downgrade

KeyBanc Capital Mkts

Overweight → Sector Weight

Feb-08-17

Initiated

Barclays

Equal Weight

$17

Nov-04-16

Initiated

Cantor Fitzgerald

Buy

Apr-08-16

Resumed

Piper Jaffray

Neutral

Jan-08-16

Reiterated

Canaccord Genuity

Buy

$17.50 → $14.50

Nov-10-15

Downgrade

Raymond James

Outperform → Mkt Perform

Jul-24-15

Initiated

KeyBanc Capital Mkts

Overweight

Jun-19-14

Upgrade

Canaccord Genuity

Hold → Buy

$16.25 → $20

Oct-09-12

Reiterated

Canaccord Genuity

Hold

$14 → $13.50

Jun-25-12

Downgrade

Canaccord Genuity

Buy → Hold

$16.50 → $14.50

Jul-15-11

Upgrade

Stifel Nicolaus

Hold → Buy

$16.50

Jul-15-11

Upgrade

Canaccord Genuity

Hold → Buy

$15 → $16.50

Jun-14-11

Downgrade

Wedbush

Neutral → Underperform

$14 → $12

Sep-08-10

Reiterated

Wedbush

Neutral

$17.50 → $14

Nov-26-20 08:58AM	Cooper Companies (COO) to Post Q4 Earnings: What's in Store? Zacks
Nov-25-20 07:47AM	What's in Store for Patterson Companies' (PDCO) Q2 Earnings? Zacks +10.36%
07:44AM	Veeva Systems (VEEV) to Post Q3 Earnings: What's in Store? Zacks
Nov-17-20 08:48AM	AngioDynamics (ANGO) Shows Solid Results from RAPID Database Zacks
Nov-12-20 09:00AM	AngioDynamics Announces Presentation of Positive Safety, Efficacy Results from RAPID Outcomes Database Business Wire
08:39AM	HMS Holdings (HMSY) Climbs 7.4% Post In-Line Q3 Earnings Zacks
Nov-11-20 06:11AM	AMN Healthcare (AMN) Loses 9.4% Despite Q3 Earnings Beat Zacks
Nov-10-20 04:46PM	Glaukos (GKOS) Beats Estimates on Narrower-than-Expected Loss (revised) Zacks
08:45AM	Glaukos (GKOS) Gains 11.8% Despite Reporting Loss in Q3 Zacks
08:07AM	Luminex (LMNX) Declines 6.6% as Q3 Earnings Miss Estimates Zacks
Nov-09-20 10:02AM	Co-Diagnostics (CODX) to Post Q3 Earnings: What's in Store? Zacks
08:09AM	Nevro (NVRO) Rallies 1.3% Despite Delivering Loss in Q3 Zacks
Nov-06-20 09:01AM	LHC Group (LHCG) Q3 Earnings and Revenues Beat Estimates Zacks
08:09AM	Inogen (INGN) Stock Loses 9.2% After Delivering Loss in Q3 Zacks
08:07AM	PRA Health (PRAH) Gains 4.3% Following Q3 Earnings Beat Zacks
Nov-05-20 10:41AM	Becton Dickinson (BDX) Earnings Surpass Estimates in Q4 Zacks
10:40AM	DENTSPLY SIRONA (XRAY) Q3 Earnings & Revenues Beat Estimates Zacks
10:07AM	Insulet (PODD) Q3 Earnings & Revenues Top Estimates, View Up Zacks
09:56AM	Fresenius Medical (FMS) Stock Gains 5.6% on Q3 Earnings Beat Zacks
09:55AM	Change Healthcare (CHNG) Q2 Earnings & Revenues Top Estimates Zacks
09:51AM	Cardinal Health (CAH) Q1 Earnings and Revenues Beat Estimates Zacks
09:49AM	AmerisourceBergen (ABC) Q4 Earnings & Revenues Top Estimates Zacks
09:13AM	Surmodics (SRDX) Reports Q4 Loss, Revenues Beat Estimates Zacks
Nov-04-20 08:39AM	Pacific Biosciences (PACB) Loses 4.1% Post Reporting Q3 Loss Zacks
08:34AM	Avanos Medical (AVNS) Q3 Earnings and Revenues Top Estimates Zacks
Nov-03-20 10:19AM	McKesson (MCK) Q2 Earnings and Revenues Surpass Estimates Zacks
09:27AM	Accuray (ARAY) Climbs 11.5% as Q1 Earnings Beat Estimates Zacks
Nov-02-20 10:41AM	OPKO Health (OPK) Loses 16.2% Despite In-Line Q3 Earnings Zacks
08:48AM	Allscripts (MDRX) Declines 1.9% Despite Q3 Earnings Beat Zacks
Oct-30-20 10:45AM	Integer Holdings (ITGR) Q3 Earnings Beat Estimates, Down Y/Y Zacks
10:40AM	Stryker (SYK) Q3 Earnings and Revenues Surpass Estimates Zacks
07:55AM	Merit Medical (MMSI) Rallies 4.8% Post Q3 Earnings Beat Zacks
07:07AM	DaVita (DVA) Earnings Beat Estimates in Q3, Revenues Miss Zacks
Oct-29-20 11:30AM	AngioDynamics (ANGO) Down 12.1% Since Last Earnings Report: Can It Rebound? Zacks
11:08AM	Globus Medical (GMED) Q3 Earnings Beat, U.S. Business Strong Zacks
10:21AM	Baxter (BAX) Q3 Earnings and Revenues Surpass Estimates Zacks
09:08AM	ABIOMED (ABMD) Earnings and Revenues Beat Estimates in Q2 Zacks
09:03AM	CONMED (CNMD) Earnings and Revenues Surpass Estimates in Q3 Zacks
07:58AM	Cerner (CERN) Q3 Earnings Surpass Estimates, Revenues Miss Zacks
07:56AM	PerkinElmer (PKI) Q3 Earnings and Revenues Surpass Estimates Zacks
Oct-23-20 06:35AM	Who Has Been Buying AngioDynamics, Inc. (NASDAQ:ANGO) Shares? Simply Wall St.
Oct-16-20 12:00PM	AngioDynamics (ANGO) Upgraded to Strong Buy: What Does It Mean for the Stock? Zacks
Oct-13-20 08:37AM	Here's Why You Should Add AngioDynamics to Your Portfolio Now Zacks
Oct-05-20 08:44AM	AngioDynamics' Shares March Higher, Can It Continue? Zacks
Sep-30-20 07:38AM	AngioDynamics (ANGO) Q1 Earnings and Revenues Top Estimates Zacks -5.34%
Sep-29-20 02:36PM	Beyond Meat, Sohu.com: 5 Top Stock Gainers for Tuesday TheStreet.com +19.40%
12:00PM	AngioDynamics Inc (ANGO) Q1 2021 Earnings Call Transcript Motley Fool
08:44AM	AngioDynamics (ANGO) in Focus: Stock Moves 6.2% Higher Zacks
08:15AM	AngioDynamics (ANGO) Tops Q1 Earnings and Revenue Estimates Zacks
07:00AM	AngioDynamics Reports Fiscal 2021 First Quarter Financial Results Business Wire
06:00AM	AngioDynamics, Inc. to Host Earnings Call ACCESSWIRE
Sep-28-20 10:07AM	Earnings Outlook For AngioDynamics Benzinga +6.17%
Sep-22-20 12:30PM	Earnings Preview: AngioDynamics (ANGO) Q1 Earnings Expected to Decline Zacks
08:37AM	AngioDynamics Unveils Auryon Atherectomy System for PAD Zacks
Sep-21-20 08:00AM	AngioDynamics Announces Commercial Launch of Auryon Atherectomy System in United States Business Wire
Sep-17-20 04:01PM	AngioDynamics to Report Fiscal 2021 First Quarter Financial Results on September 29, 2020 Business Wire
Aug-17-20 08:00AM	AngioDynamics Announces First Patient Enrolled in PATHFINDER I Registry Examining Long-Term Effectiveness and Safety of Auryon Atherectomy System Business Wire
Aug-15-20 11:30AM	Why Is AngioDynamics (ANGO) Down 1.3% Since Last Earnings Report? Zacks
Aug-05-20 08:32AM	New Strong Sell Stocks for August 5th Zacks
Aug-04-20 08:09AM	Edited Transcript of ANGO.OQ earnings conference call or presentation 16-Jul-20 12:00pm GMT Thomson Reuters StreetEvents +7.30%
Aug-03-20 04:01PM	AngioDynamics to Participate in a Virtual Fireside Chat at the Canaccord Genuity Growth Conference Business Wire
09:32AM	New Strong Sell Stocks for August 3rd Zacks
Jul-17-20 08:14AM	AngioDyanamics (ANGO) Reports Q4 Loss, Revenues Lag Estimates Zacks
Jul-16-20 02:30PM	AngioDynamics Inc (ANGO) Q4 2020 Earnings Call Transcript Motley Fool -11.51%
08:15AM	AngioDynamics (ANGO) Reports Q4 Loss, Lags Revenue Estimates Zacks
07:25AM	AngioDynamics: Q4 Earnings Insights Benzinga
07:00AM	AngioDynamics Reports Fiscal 2020 Fourth Quarter and Full-Year Financial Results Business Wire
Jul-09-20 12:30PM	Analysts Estimate AngioDynamics (ANGO) to Report a Decline in Earnings: What to Look Out for Zacks
Jul-08-20 08:48AM	AngioDynamics (NASDAQ:ANGO) Share Prices Have Dropped 52% In The Last Year Simply Wall St.
Jul-04-20 03:00PM	Hedge Funds Never Been Less Bullish On AngioDynamics, Inc. (ANGO) Insider Monkey
Jun-23-20 04:01PM	AngioDynamics to Report Fiscal 2020 Fourth Quarter and Full-Year Financial Results on July 16, 2020 Business Wire
Jun-17-20 09:16AM	Buy These 5 Low Leverage Stocks to Avoid Debt-Related Risk Zacks
Jun-15-20 10:04AM	Here's Why You Should Add AngioDynamics to Your Portfolio Zacks +6.63%
Jun-08-20 04:01PM	AngioDynamics to Participate in a Virtual Fireside Chat at the Raymond James Human Health Innovation Conference Business Wire
Jun-01-20 04:52PM	Edited Transcript of ANGO earnings conference call or presentation 7-Apr-20 12:00pm GMT Thomson Reuters StreetEvents
May-07-20 04:01PM	AngioDynamics to Present at the UBS Virtual Global Healthcare Conference Business Wire
11:30AM	AngioDynamics (ANGO) Down 1.6% Since Last Earnings Report: Can It Rebound? Zacks
Apr-13-20 02:32PM	AngioDynamics slows spending as hospitals delay elective surgeries amid coronavirus American City Business Journals -8.50%
Apr-09-20 07:28AM	AngioDyanamics (ANGO) Q3 Earnings and Revenues Top Estimates Zacks +5.23%
Apr-07-20 09:46AM	Recap: AngioDynamics Q3 Earnings Benzinga
08:15AM	AngioDynamics (ANGO) Beats Q3 Earnings and Revenue Estimates Zacks
07:00AM	AngioDynamics Reports Fiscal 2020 Third Quarter Financial Results Business Wire
06:00AM	AngioDynamics, Inc. to Host Earnings Call ACCESSWIRE
Apr-01-20 06:30AM	AngioDynamics, Inc. (NASDAQ:ANGO): Are Analysts Optimistic? Simply Wall St. -7.48%
Mar-31-20 12:30PM	Earnings Preview: AngioDynamics (ANGO) Q3 Earnings Expected to Decline Zacks
Mar-25-20 12:00PM	AngioDynamics (ANGO) Upgraded to Buy: Here's What You Should Know Zacks
Mar-10-20 04:01PM	AngioDynamics to Report Fiscal 2020 Third Quarter Financial Results on April 7, 2020 Business Wire
Feb-27-20 04:01PM	AngioDynamics to Present at Two Investor Conferences in March Business Wire
Feb-26-20 06:00AM	AngioDynamics investing $7 million in Glens Falls and Queensbury American City Business Journals
Feb-09-20 09:34AM	Calculating The Intrinsic Value Of AngioDynamics, Inc. (NASDAQ:ANGO) Simply Wall St.
Feb-06-20 11:30AM	AngioDynamics (ANGO) Down 10.4% Since Last Earnings Report: Can It Rebound? Zacks
08:00AM	AngioDynamics Appoints Stephen Trowbridge Executive Vice President and Chief Financial Officer Business Wire
Jan-16-20 11:00AM	AngioDynamics Launches PATHFINDER I Registry to Evaluate Performance and Clinical Outcomes of the AURYON Atherectomy System Business Wire
Jan-09-20 06:27PM	Edited Transcript of ANGO earnings conference call or presentation 7-Jan-20 1:00pm GMT Thomson Reuters StreetEvents
07:06AM	Here's Why You Should Hold on to AngioDynamics Stock Now Zacks
Jan-08-20 09:02AM	AngioDynamics (ANGO) Q2 Earnings Top, Revenues Lag Estimates Zacks
06:00AM	AngioDynamics' latest acquisition will boost $95 million business line American City Business Journals
Jan-07-20 08:15AM	AngioDynamics (ANGO) Beats Q2 Earnings Estimates Zacks -9.05%
07:00AM	AngioDynamics Reports Fiscal 2020 Second Quarter Financial Results Business Wire
Jan-06-20 08:00AM	AngioDynamics to Present at the J.P. Morgan Healthcare Conference Business Wire

AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors. It also offers BioSentry tract sealant systems, IsoLoc Endorectal Balloon's, alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. In addition, the company provides vascular interventions and therapies products in the areas of thrombus management, atherectomy, peripheral products (Core), and venous insufficiency. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies under the BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax names. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Trowbridge Stephen A	EVP and CFO	Aug 11	Buy	9.38	1,013	9,502	60,273	Aug 12 04:14 PM
Clemmer James C	President and CEO	Jul 31	Buy	8.26	40,000	330,400	343,319	Aug 03 05:27 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience